Chungdamglobal Co., Ltd.

Chungdamglobal Co., Ltd.

KKRX:362320
4,610.00
KRW
+65.00
(+1.43%)
316.48EPS
22.41P/E
90.96BMarket Cap
Nov 12Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
308,647.27
5,097.15
9,554.55
11,725.55
11,568.09
8,634.7
10,806.73
11,621.32
Basic EPS, GAAP
8,783.97
47
388
252
-87
72.34
93
199.43
Free Cash Flow per Basic Share
-26,863.49
-930.9
-325.29
7.18
-540.86
-353.27
-1,161.6
-1,843.83
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
166.75
223.08
1,279.17
3,142.87
3,130.97
3,764.46
4,268.22
4,875.79
Tangible Book Value per Share
165.7
220.85
1,273.86
3,127.84
3,043.62
3,480.49
3,784.63
4,358.6
Basic Weighted Avg Shares
- -
15
15
18
21
27
20
20
Sales/Revenue/Turnover
37,038
77,017
144,348
216,298
237,779
234,266
217,385
235,604
Operating Margin (%)
2.87
4.74
6.73
3.56
2.41
2.93
2.89
1.4
Depreciation Expense
135
331
728
962
1,688
2,143
2,838
2,681
Net Income, GAAP
1,054
710
5,862
4,649
-1,788
1,963
1,871
4,043
Effective Tax Rate (%)
20.04
39.38
27.22
25.3
299.32
34.74
30.38
30.41
Profit Margin (%)
2.85
0.92
4.06
2.15
-0.75
0.84
0.86
1.72
Working Capital
8,061
17,586
28,661
57,001
52,709
85,262
95,556
129,521
LT Debt
3,560
16,561
7,996
5,507
804
18,203
9,261
34,651
Total Equity
3,911
4,892
27,051
66,690
66,845
86,418
117,162
129,887
Return on Invested Capital (%)
- -
14.65
22.95
9.85
-13.38
3.91
2.37
0.77
Return on Capital (%)
- -
13.38
25.98
9.64
-6.25
2.03
2.07
2.68
Return on Common Equity (%)
- -
17.73
37.97
10.23
-2.8
2.85
2.32
4.36

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
55,208
37,905
44,062
LT Borrowings
8,541
33,348
34,413
LT Finance Leases
721
390
238
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
122,706
97,367
90,958

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
172,987
203,258
194,968
Cash, Cash Equivalents & STI
47,084
51,321
31,273
Accounts Receivable, Net
81,304
103,159
99,060
Inventories
26,311
29,909
35,404
Total Current Liabilities
77,432
71,160
65,448
Payables & Accruals
- -
- -
- -
ST Debt
55,208
37,905
44,062
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
132.91%
35.58%
Free Cash Flow
- -
-1,705.88%
143.79%
Net Income, GAAP
- -
70.36%
-4.68%
Sales/Revenue/Turnover
- -
27.7%
-7.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
54,796
65,835
62,470
51,165
234,266
2025
54,281
41,727
51,478
69,899
217,385
2026
48,323
65,904
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
132
46
61
-156.62
72.34
2025
122
-13
137.45
-150.78
93
2026
309.5
-98
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Seok-Ju Choi
Full Time Employees
67
Sector
Distribution services
Industry
Medical distributors
Address
Seoul South Korea
IPO Date
Jun 3, 2022
Business
Chungdamglobal Co., Ltd. is a South Korea-based cross-border e-commerce distribution platform and brand accelerator specializing in the sourcing, distribution, marketing, and fulfillment of beauty, healthcare, and lifestyle consumer products. Founded in 2017 and headquartered in Seoul, South Korea, the company connects brand manufacturers with global consumer markets through integrated digital commerce infrastructure and localized omni-channel retail networks across Mainland China, the United States, Europe, Japan, and Southeast Asia. The company operates across multiple integrated business segments offering: cosmetics and skincare products, including facial toners, serums, ampoules, moisturizing creams, sunscreens, sheet masks, cleansing formulations, and color cosmetics sourced from leading and emerging Korean beauty brands; medical aesthetic and bio-pharmaceutical products, comprising hyaluronic acid (HA) dermal fillers, skin boosters, polynucleotide (PN) injectables, and anti-aging aesthetic solutions developed and manufactured through its subsidiary Biobijou Co., Ltd.; health functional foods and consumer wellness goods, including nutritional dietary supplements, vitamins, infant care products, and personal hygiene essentials; entertainment merchandise, encompassing official K-pop albums, photo books, light sticks, and licensed idol goods distributed globally through its subsidiary idOLSTORE; and end-to-end cross-border commerce enablement solutions, encompassing brand incubation and localization consulting; regulatory licensing and pre-authorization clearance; influencer-driven live commerce and multi-channel network (MCN) marketing; storefront operations on major digital platforms including JD.com, Alibaba Tmall Global, Douyin, Kuaishou, Xiaohongshu, Amazon, and TikTok Shop; and bonded warehousing, customs clearance, and international fulfillment logistics. In recent developments, Chungdamglobal has executed a strategic shift from traditional business-to-business (B2B) distribution toward high-margin social-to-consumer (S2C) and direct-to-consumer (D2C) live-streaming commerce. The company accelerated its Western market expansion beyond Greater China through the acquisition and operational integration of U.S.-based e-commerce solution provider Kreassive LLC, scaling brand sales across Amazon and TikTok Shop in North America and Europe. In corporate milestones, the company successfully completed the initial public offering and KOSDAQ listing of its medical aesthetics subsidiary Biobijou Co., Ltd. and secured a 4 billion KRW strategic investment for its entertainment retail subsidiary idOLSTORE from WE Ventures at a 30 billion KRW valuation. In addition, Chungdamglobal formed multi-party strategic distribution partnerships, including alliances with Be'Balance and UUL&P, to accelerate the global commercial expansion of partner brands across North American, Chinese, and Southeast Asian retail channels.